Gv 2021 Gp, L.l.c. - Insider Trading Tracker

GitLab Inc.

US ˙ NasdaqGS ˙ US37637K1088

Introduction

This page provides a comprehensive analysis of the known insider trading history of Gv 2021 Gp, L.l.c.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders

Companies with Reported Insider Positions

The SEC filings indicate Gv 2021 Gp, L.l.c. has reported holdings or trades in the following companies:

Security	Title	Latest Reported Holdings
	10% Owner	3,262,440
US:GTLB / GitLab Inc.		2,647,312

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Gv 2021 Gp, L.l.c.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GTLB / GitLab Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GTLB / GitLab Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2023-05-05	GTLB	GV 2021 GP, L.L.C.	7,286	26.9810	7,286	26.9810	196,584	280	77.6000	368,811	187.61
2023-05-04	GTLB	GV 2021 GP, L.L.C.	302,483	26.7533	302,483	26.7533	8,092,418
2023-05-04	GTLB	GV 2021 GP, L.L.C.	91,710	27.6522	91,710	27.6522	2,535,983
2023-05-04	GTLB	GV 2021 GP, L.L.C.	2,168	28.2580	2,168	28.2580	61,263
2023-05-03	GTLB	GV 2021 GP, L.L.C.	287,470	28.2952	287,470	28.2952	8,134,021
2023-05-03	GTLB	GV 2021 GP, L.L.C.	22,461	28.9527	22,461	28.9527	650,307
2023-03-14	GTLB	GV 2021 GP, L.L.C.	169,156	30.3030	169,156	30.3030	5,125,934
2023-03-14	GTLB	GV 2021 GP, L.L.C.	55,051	30.9678	55,051	30.9678	1,704,808
2023-03-13	GTLB	GV 2021 GP, L.L.C.	119,798	28.2554	119,798	28.2554	3,384,940
2023-03-13	GTLB	GV 2021 GP, L.L.C.	152,251	29.1180	152,251	29.1180	4,433,245
2023-03-13	GTLB	GV 2021 GP, L.L.C.	126,938	30.2739	126,938	30.2739	3,842,908
2023-03-13	GTLB	GV 2021 GP, L.L.C.	16,013	30.9942	16,013	30.9942	496,310
2022-11-09	GTLB	GV 2021 GP, L.L.C.	128,911	34.2931	128,911	34.2931	4,420,758
2022-11-09	GTLB	GV 2021 GP, L.L.C.	42,833	35.1508	42,833	35.1508	1,505,614
2022-11-09	GTLB	GV 2021 GP, L.L.C.	10,568	36.0939	10,568	36.0939	381,440
2022-11-08	GTLB	GV 2021 GP, L.L.C.	14,264	35.9663	14,264	35.9663	513,023
2022-11-08	GTLB	GV 2021 GP, L.L.C.	25,159	36.3752	25,159	36.3752	915,164
2022-11-07	GTLB	GV 2021 GP, L.L.C.	136,376	34.9056	136,376	34.9056	4,760,286
2022-11-07	GTLB	GV 2021 GP, L.L.C.	65,421	35.6900	65,421	35.6900	2,334,875
2022-11-07	GTLB	GV 2021 GP, L.L.C.	100	36.4100	100	36.4100	3,641
2022-11-04	GTLB	GV 2021 GP, L.L.C.	121,424	35.5257	121,424	35.5257	4,313,673
2022-11-04	GTLB	GV 2021 GP, L.L.C.	141,028	36.2899	141,028	36.2899	5,117,892
2022-11-04	GTLB	GV 2021 GP, L.L.C.	15,041	37.2111	15,041	37.2111	559,692
2022-05-24	GTLB	GV 2021 GP, L.L.C.	13,528	33.7189	13,528	33.7189	456,149
2022-05-12	GTLB	GV 2021 GP, L.L.C.	14,860	32.9636	14,860	32.9636	489,839
2022-05-12	GTLB	GV 2021 GP, L.L.C.	9,183	33.7340	9,183	33.7340	309,779
2022-05-11	GTLB	GV 2021 GP, L.L.C.	76,136	34.7095	76,136	34.7095	2,642,642
2022-05-10	GTLB	GV 2021 GP, L.L.C.	82,055	33.7184	82,055	33.7184	2,766,763
2022-05-10	GTLB	GV 2021 GP, L.L.C.	77,391	34.4586	77,391	34.4586	2,666,786
2022-05-10	GTLB	GV 2021 GP, L.L.C.	80,488	35.4065	80,488	35.4065	2,849,798
2022-05-10	GTLB	GV 2021 GP, L.L.C.	15,513	36.5711	15,513	36.5711	567,327
2022-05-10	GTLB	GV 2021 GP, L.L.C.	200	37.0000	200	37.0000	7,400

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales GTLB / GitLab Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GTLB / GitLab Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Gv 2021 Gp, L.l.c. as disclosed to the Securities Exchange Commission (SEC).

File Date	Tran Date	Form	Ticker	Security	Code	10b5-1	Shares	Remaining Shares	Percent Change	Share Price	Tran Value	Remaining Value
2025-08-05	2025-08-01	4	PRME	Prime Medicine, Inc. Common Stock	P - Purchase		1,500,000	3,262,440	85.11	3.30	4,950,000	10,766,052
2023-06-22	2023-06-21	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-19,003	0	-100.00	14.97	-284,496
2023-06-22	2023-06-21	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-19,003	10,100,058	-0.19
2023-06-22	2023-06-20	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-37,405	0	-100.00	15.06	-563,248
2023-06-22	2023-06-20	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-37,405	10,119,061	-0.37
2023-06-20	2023-06-16	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-6,532	0	-100.00	15.02	-98,109
2023-06-20	2023-06-16	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-6,532	10,156,466	-0.06
2023-06-20	2023-06-15	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-66,659	0	-100.00	14.92	-994,326
2023-06-20	2023-06-15	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-66,659	10,162,998	-0.65
2023-06-15	2023-06-14	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-28,960	0	-100.00	14.87	-430,684
2023-06-15	2023-06-14	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-28,960	10,229,657	-0.28
2023-06-15	2023-06-13	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-28,100	0	-100.00	15.13	-425,102
2023-06-15	2023-06-13	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-28,100	10,258,617	-0.27
2023-06-13	2023-06-12	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-16,031	0	-100.00	14.98	-240,151
2023-06-13	2023-06-12	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-16,031	10,286,717	-0.16
2023-06-13	2023-06-09	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-15,672	0	-100.00	14.48	-226,984
2023-06-13	2023-06-09	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-15,672	10,302,748	-0.15
2023-06-09	2023-06-08	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-5,000	0	-100.00	15.74	-78,686
2023-06-09	2023-06-08	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-5,000	10,318,420	-0.05
2023-06-09	2023-06-07	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-15,000	0	-100.00	16.92	-253,870
2023-06-09	2023-06-07	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-15,000	10,323,420	-0.15
2023-06-07	2023-06-06	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-29,975	0	-100.00	17.02	-510,166
2023-06-07	2023-06-06	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-29,975	10,338,420	-0.29
2023-06-07	2023-06-05	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-22,434	0	-100.00	16.70	-374,612
2023-06-07	2023-06-05	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-22,434	10,368,395	-0.22
2023-06-02	2023-06-01	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-471	0	-100.00	14.75	-6,949
2023-06-02	2023-06-01	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-44,752	471	-98.96	14.35	-642,245	6,759
2023-06-02	2023-06-01	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-45,223	10,390,829	-0.43
2023-06-02	2023-05-31	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-16,633	0	-100.00	13.65	-227,004
2023-06-02	2023-05-31	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-16,633	10,436,052	-0.16
2023-05-31	2023-05-30	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-16,805	0	-100.00	13.70	-230,240
2023-05-31	2023-05-30	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-16,805	10,452,685	-0.16
2023-05-31	2023-05-26	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-12,602	0	-100.00	13.70	-172,603
2023-05-31	2023-05-26	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-12,602	10,469,490	-0.12
2023-05-26	2023-05-25	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-23,161	0	-100.00	13.38	-309,973
2023-05-26	2023-05-25	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-23,161	10,482,092	-0.22
2023-05-26	2023-05-24	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-7,900	0	-100.00	13.66	-107,920
2023-05-26	2023-05-24	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-7,900	10,505,253	-0.08
2023-05-24	2023-05-23	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-43,939	0	-100.00	14.74	-647,648
2023-05-24	2023-05-23	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-43,939	10,513,153	-0.42
2023-05-24	2023-05-22	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-87,922	0	-100.00	14.13	-1,242,092
2023-05-24	2023-05-22	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-87,922	10,557,092	-0.83
2023-05-22	2023-05-19	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-63,212	0	-100.00	13.88	-877,066
2023-05-22	2023-05-19	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-63,212	10,645,014	-0.59
2023-05-22	2023-05-18	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-14,022	0	-100.00	13.06	-183,171
2023-05-22	2023-05-18	4	PRME	Prime Medicine, Inc. Common Stock	J - Other	X	-14,022	10,708,226	-0.13
2023-05-22	2023-05-18	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-13,076	10,722,248	-0.12	13.01	-170,100	139,481,435
2023-05-18	2023-05-17	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-15,000	10,735,324	-0.14	12.77	-191,600	137,125,514
2023-05-18	2023-05-16	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-50,649	10,750,324	-0.47	12.59	-637,676	135,347,654
2023-05-16	2023-05-15	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-157,952	10,800,973	-1.44	12.74	-2,012,087	137,589,275
2023-05-16	2023-05-12	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-27,290	10,958,925	-0.25	12.72	-347,222	139,434,786
2023-05-12	2023-05-11	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-4,807	10,986,215	-0.04	13.79	-66,290	151,503,201
2023-05-12	2023-05-11	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-21,819	10,991,022	-0.20	12.98	-283,243	142,679,952
2023-05-12	2023-05-10	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-87,397	11,012,841	-0.79	14.03	-1,225,804	154,462,804
2023-05-10	2023-05-09	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-321,238	11,100,238	-2.81	14.08	-4,522,613	156,276,921
2023-05-10	2023-05-08	4	PRME	Prime Medicine, Inc. Common Stock	S - Sale	X	-100,772	11,421,476	-0.87	14.13	-1,423,727	161,364,897
2023-05-09	2023-05-05	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		7,286	2,647,312	0.28	26.98	196,584	71,427,125
2023-05-05	2023-05-04	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		2,168	2,640,026	0.08	28.26	61,263	74,601,855
2023-05-05	2023-05-04	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		91,710	2,637,858	3.60	27.65	2,535,983	72,942,577
2023-05-05	2023-05-04	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		302,483	2,546,148	13.48	26.75	8,092,418	68,117,861
2023-05-05	2023-05-03	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		22,461	2,243,665	1.01	28.95	650,307	64,960,160
2023-05-05	2023-05-03	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		287,470	2,221,204	14.87	28.30	8,134,021	62,849,411
2023-03-15	2023-03-14	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		55,051	1,933,734	2.93	30.97	1,704,808	59,883,488
2023-03-15	2023-03-14	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		169,156	1,878,683	9.89	30.30	5,125,934	56,929,731
2023-03-15	2023-03-13	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		16,013	1,709,527	0.95	30.99	496,310	52,985,422
2023-03-15	2023-03-13	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		126,938	1,693,514	8.10	30.27	3,842,908	51,269,273
2023-03-15	2023-03-13	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		152,251	1,566,576	10.76	29.12	4,433,245	45,615,560
2023-03-15	2023-03-13	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		119,798	1,414,325	9.25	28.26	3,384,940	39,962,319
2022-11-10	2022-11-09	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		10,568	1,294,527	0.82	36.09	381,440	46,724,528
2022-11-10	2022-11-09	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		42,833	1,283,959	3.45	35.15	1,505,614	45,132,186
2022-11-10	2022-11-09	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		128,911	1,241,126	11.59	34.29	4,420,758	42,562,058
2022-11-10	2022-11-08	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		25,159	1,112,215	2.31	36.38	915,164	40,457,043
2022-11-10	2022-11-08	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		14,264	1,087,056	1.33	35.97	513,023	39,097,382
2022-11-08	2022-11-07	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		100	1,072,792	0.01	36.41	3,641	39,060,357
2022-11-08	2022-11-07	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		65,421	1,072,692	6.49	35.69	2,334,875	38,284,377
2022-11-08	2022-11-07	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		136,376	1,007,271	15.66	34.91	4,760,286	35,159,399
2022-11-08	2022-11-04	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		15,041	870,895	1.76	37.21	559,692	32,406,961
2022-11-08	2022-11-04	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		141,028	855,854	19.73	36.29	5,117,892	31,058,856
2022-11-08	2022-11-04	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		121,424	714,826	20.46	35.53	4,313,673	25,394,694
2022-10-26	2022-10-24	4	PRME	Prime Medicine, Inc. Common Stock	P - Purchase		800,000	11,522,248	7.46	17.00	13,600,000	195,878,216
2022-10-26	2022-10-24	4	PRME	Prime Medicine, Inc. Common Stock	C - Conversion		1,762,440	1,762,440
2022-10-26	2022-10-24	4	PRME	Prime Medicine, Inc. Common Stock	C - Conversion		10,722,248	10,722,248
2022-05-25	2022-05-24	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		13,528	593,402	2.33	33.72	456,149	20,008,863
2022-05-16	2022-05-12	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		9,183	579,874	1.61	33.73	309,779	19,561,470
2022-05-16	2022-05-12	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		14,860	570,691	2.67	32.96	489,839	18,812,030
2022-05-12		3	GTLB	Gitlab Inc. Class A Common Stock				224,048
2022-05-12	2022-05-11	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		76,136	555,831	15.87	34.71	2,642,642	19,292,616
2022-05-12	2022-05-10	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		200	479,695	0.04	37.00	7,400	17,748,715
2022-05-12	2022-05-10	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		15,513	479,495	3.34	36.57	567,327	17,535,660
2022-05-12	2022-05-10	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		80,488	463,982	20.99	35.41	2,849,798	16,427,979
2022-05-12	2022-05-10	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		77,391	383,494	25.28	34.46	2,666,786	13,214,666
2022-05-12	2022-05-10	4	GTLB	Gitlab Inc. Class A Common Stock	P - Purchase		82,055	306,103	36.62	33.72	2,766,763	10,321,303

Open market or private purchase of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award, or other acquisition of securities from the company (such as an option)

Conversion of derivative

Sale or transfer of securities back to the company

Payment of exercise price or tax liability using portion of securities received from the company

Gift of securities by or to the insider

Equity swaps and similar hedging transactions

Exercise or conversion of derivative security received from the company (such as an option)

A transaction voluntarily reported on Form 4

Other (accompanied by a footnote describing the transaction)